Nektar Therapeutics
ID: 4350700A biopharmaceutical company developing therapeutics for treating cancer, auto-immune disease, and chronic pain using their chemistry technology platform.
1
Funding Rounds
$25.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ho**** Ro*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** L. Ko**** | - | - | - |
| Jo****** Za****** | - | - | - |
| Ji***** B. Th***** | - | - | - |
| Ma** A. Wi**** | - | - | |
| Je****** Ru***** | - | - | |
| Ke*** Br****** | - | - | - |
| Ma** Ta********* | - | - | |
| Ro**** Ba*** | - | - | - |
Funding series
Funding Series Analysis
The company Nektar Therapeutics has raised a total of $25m in funding over 1 rounds.
Key Insights:
- Nektar Therapeutics funding round, August 2013: $25m
Industries
Nektar Therapeutics is active in the following industries: